Tiffany Nicole Heady

Affiliations: 
2001 University of Virginia, Charlottesville, VA 
Google:
"Tiffany Heady"
Mean distance: 8.25
 

Parents

Sign in to add mentor
Timothy L. Macdonald grad student 2001 UVA
 (Design and synthesis of novel calcium influx inhibitors: Work towards a cytostatic cancer therapy.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lee PJ, Bhonsle JB, Gaona HW, et al. (2009) Targeting the fatty acid biosynthesis enzyme, beta-ketoacyl-acyl carrier protein synthase III (PfKASIII), in the identification of novel antimalarial agents. Journal of Medicinal Chemistry. 52: 952-63
Dow GS, Heady TN, Bhattacharjee AK, et al. (2006) Utility of alkylaminoquinolinyl methanols as new antimalarial drugs. Antimicrobial Agents and Chemotherapy. 50: 4132-43
McCalmont WF, Patterson JR, Lindenmuth MA, et al. (2005) Investigation into the structure-activity relationship of novel concentration dependent, dual action T-type calcium channel agonists/antagonists. Bioorganic & Medicinal Chemistry. 13: 3821-39
Gray L, Perez-Reyes E, Gomora J, et al. (2005) Erratum to “The role of voltage gated T-type Ca2+ channel isoforms in mediating “capacitative” Ca2+ entry in cancer cells” [Cell Calcium 36 (2004) 489–497] Cell Calcium. 37: 603
Gray LS, Perez-Reyes E, Gomora JC, et al. (2004) The role of voltage gated T-type Ca2+ channel isoforms in mediating "capacitative" Ca2+ entry in cancer cells. Cell Calcium. 36: 489-97
McCalmont WF, Heady TN, Patterson JR, et al. (2004) Design, synthesis, and biological evaluation of novel T-Type calcium channel antagonists. Bioorganic & Medicinal Chemistry Letters. 14: 3691-5
Smith KS, Smith PL, Heady TN, et al. (2003) In vitro metabolism of tolcapone to reactive intermediates: relevance to tolcapone liver toxicity. Chemical Research in Toxicology. 16: 123-8
Heady TN, Gomora JC, Macdonald TL, et al. (2001) Molecular pharmacology of T-type Ca2+ channels. Japanese Journal of Pharmacology. 85: 339-50
Haverstick DM, Heady TN, Macdonald TL, et al. (2000) Inhibition of human prostate cancer proliferation in vitro and in a mouse model by a compound synthesized to block Ca2+ entry. Cancer Research. 60: 1002-8
See more...